Skip to content
Search

Latest Stories

Kinnock vows "greater role" for pharmacists with contract negotiations to restart in New Year

Kinnock pharmacists role
pharmacist consultation (gettyimages)

Pharmacy minister Stephen Kinnock said pharmacies have a “greater role” in providing healthcare on the high street in response to a parliamentary debate that saw MPs from all three major parties urging for greater funding for the sector.

Kinnock announced that negotiations for a new pharmacy contract will begin in the New Year.


"I know that hon. Members across the House will be very interested in that, in terms of the contractual framework, the medicines margin and all of the funding," he said.

"We have a statutory duty to consult with the sector before we can make any announcement, but we are confident that we will start the negotiations early in the New Year."

The debate in parliament, which was secured by Liberal Democrat MP, Rachel Gilmore, involved 20 MPs who insisted the sector "could do even more to improve access to primary care”.

The focus of the debate was on pharmacies in the Devon and the south West region, though its was highlighted that pharmacies facing financial strain was a national issue.

Gilmore started the debate by explaining that fewer pharmacies are open now than at any time since 2008/09 “even though their workload is 40 per cent higher, in terms of annual prescriptions.”

She added: "The increase in workload is not sustainable, but that workload is too important not to receive proper backing from central government as they make headway on their ambition to create what they have referred to as a neighbourhood health service."

Kinnock praised community pharmacies for their "professionalism, hard work and dedication in providing excellent standards of patient care".

He added: “We want pharmacists to be providing new and impactful clinical services, including our future pharmacies prescribing service which will be imperative to deliver on the government’s mission and health and economic growth.”

The need for extra funding for pharmacy, which is currently working without a funding contract, was supported by Sadik Al-Hassan, the Labour MP for North Somerset and vice-chair of the All-Party Parliamentary Group on pharmacy, who said the government "must provide a fair funding settlement".

“The prescription for pharmacy is an immediate funding settlement for this year to stabilise the sector with a sticking plaster while we look at the longer-term changes the industry needs,” he added.

Janet Morrison, chief executive of Community Pharmacy England (CPE), said she hoped that debate showed the government the strength of support community pharmacy has in the midst of the "current crisis" faced by the sector.

“We are very grateful for the support of all MPs who took part in this debate to voice their support for increased funding for their local community pharmacies. Never before have we seen so many Parliamentarians recognising that pharmacies are in crisis and calling for investment,” said Morrison.

“I hope the minister noted the strength of feeling expressed at the debate from MPs worried and concerned for the long-term sustainability of healthcare provision in their communities. This of course reflects the desperation, and anger, of community pharmacy about the current crisis given all that pharmacies have done, and continue to do, for patients and the NHS.”

Morrison revealed CPE had been pushing to start negotiations for many months and that “this cannot happen quickly enough”.

“Urgent action is needed to keep pharmacies afloat and to protect communities’ access to medicine supply and health advice,” she said.

"We have been absolutely clear to Government and the NHS that without an adequate immediate funding injection they can expect to see many more closures – we look forward beginning negotiations early in the New Year.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less